This compound is primarily utilized in medicinal chemistry and pharmaceutical research as a key intermediate in the synthesis of biologically active molecules. Its spirocyclic structure makes it valuable for designing and developing novel drug candidates, particularly those targeting central nervous system disorders, such as anxiety, depression, and neurodegenerative diseases. The presence of the Boc (tert-butoxycarbonyl) group allows for selective protection and deprotection during multi-step synthetic processes, enhancing its versatility in organic synthesis. Additionally, its unique scaffold is explored for its potential in creating enzyme inhibitors and receptor modulators, contributing to the development of therapeutic agents with improved efficacy and specificity.